אונורג 200 מג Izrael - hebrejčina - Ministry of Health

אונורג 200 מג

bristol, myers squibb (israel) limited, israel - azacitidine - טבליות מצופות פילם - azacitidine 200 mg - azacitidine

אונורג 300 מג Izrael - hebrejčina - Ministry of Health

אונורג 300 מג

bristol, myers squibb (israel) limited, israel - azacitidine - טבליות מצופות פילם - azacitidine 300 mg - azacitidine

סנדאימון   ניאורל   50 מג כמוסות Izrael - hebrejčina - Ministry of Health

סנדאימון ניאורל 50 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

סנדאימון   ניאורל   100 מג כמוסות Izrael - hebrejčina - Ministry of Health

סנדאימון ניאורל 100 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

רובראקה 200 מג Izrael - hebrejčina - Ministry of Health

רובראקה 200 מג

neopharm ltd, israel - rucaparib as camsylate - טבליות מצופות פילם - rucaparib as camsylate 200 mg - rucaparib

רובראקה 250 מג Izrael - hebrejčina - Ministry of Health

רובראקה 250 מג

neopharm ltd, israel - rucaparib as camsylate - טבליות מצופות פילם - rucaparib as camsylate 250 mg - rucaparib

רובראקה 300 מג Izrael - hebrejčina - Ministry of Health

רובראקה 300 מג

neopharm ltd, israel - rucaparib as camsylate - טבליות מצופות פילם - rucaparib as camsylate 300 mg - rucaparib

ריידפט 25 מג Izrael - hebrejčina - Ministry of Health

ריידפט 25 מג

novartis israel ltd - midostaurin - קפסולות רכות - midostaurin 25 mg - midostaurin

רינבוק 15 מג Izrael - hebrejčina - Ministry of Health

רינבוק 15 מג

abbvie biopharmaceuticals ltd, israel - upadacitinib as hemihydrate - טבליות בשחרור ממושך - upadacitinib as hemihydrate 15 mg - upadacitinib

רינבוק 15 מג Izrael - hebrejčina - Ministry of Health

רינבוק 15 מג

abbvie biopharmaceuticals ltd, israel - upadacitinib as hemihydrate - טבליות בשחרור ממושך - upadacitinib as hemihydrate 15 mg - upadacitinib